Boston Globe Editorial Defends Massachusetts Cannabis Program

Editorial Stakes Out Pro-Regulation Position

The Boston Globe editorial board positioned itself against what it termed "outside fearmongering" targeting Massachusetts' adult-use cannabis program. The September 10 piece marks a notable intervention from the state's largest newspaper. The industry faces headwinds from both federal rescheduling uncertainty and local regulatory challenges.

The editorial's timing coincides with ongoing debates in several Massachusetts municipalities over dispensary licensing caps and zoning restrictions. The Globe didn't identify specific "outside" opponents by name in the available headline and description.

Massachusetts Program Context

Massachusetts launched adult-use cannabis sales in November 2018, generating over $4.8 billion in cumulative revenue through August 2026. The state's Cannabis Control Commission oversees 403 active retail licenses as of September 2026, according to CCC public data.

The program operates under Chapter 94G of the Massachusetts General Laws, which established a 10.75% state excise tax plus local option taxes up to 3%. Total effective tax rates range from 13.75% to 20% depending on municipality.

For full background on this story, see the CannIntel topic hub on Massachusetts Cannabis Program.

Federal Tax Burden Remains Core Challenge

Massachusetts cannabis businesses remain subject to IRC §280E, which disallows ordinary business expense deductions for entities trafficking in Schedule I or II controlled substances. This creates effective federal tax rates often exceeding 70% of gross profit. It's a structural disadvantage the Globe editorial implicitly addresses by defending the state program's viability.

The DEA's proposed rescheduling to Schedule III would eliminate 280E exposure but has faced delays. The NPRM comment period closed in July 2024. No final rule has been issued as of September 2026, and Massachusetts operators can't claim state-level relief from federal tax burdens.

Local Opposition Dynamics

At least 17 Massachusetts municipalities have enacted temporary moratoria or stricter caps on cannabis retail licenses since January 2026. These local actions often cite public health concerns, youth access risks, and impaired driving. The Globe editorial appears to characterize such arguments as fearmongering when advanced by non-local actors.

The editorial's framing suggests the Globe views external pressure campaigns as a threat to the regulatory framework Massachusetts voters approved in the 2016 ballot initiative.

Massachusetts General Law Chapter 94G §3(a)(2) grants municipalities local control over cannabis establishment counts and locations, creating a patchwork regulatory environment. Some communities have zero dispensaries despite statewide legalization.

What Operators Should Watch

The Globe's editorial position may influence pending municipal votes on cannabis zoning amendments scheduled for fall 2026 town meetings. Editorial board endorsements have historically correlated with voter outcomes in Massachusetts ballot questions, though the causal direction remains debated.

Cannabis businesses operating in or expanding to Massachusetts should monitor:

• Municipal cannabis advisory committee recommendations due October–November 2026
• CCC guidance on host community agreement renegotiations
• State legislative proposals to preempt certain local restrictions

The state's Social Equity Program prioritizes licenses for applicants from communities disproportionately harmed by prior enforcement. It remains a political flashpoint, and the Globe has previously editorialized in favor of expanding equity provisions.